1 – 10 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Enhancing the Prediction of Lymph Node Metastasis in Early Breast Cancer Using Deep Learning on Routine Full-Breast Mammograms
2025) In Breast Cancer Research(
- Working paper/Preprint › Preprint in preprint archive
- 2024
-
Mark
Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer
(
- Contribution to journal › Article
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
(
- Contribution to journal › Article
-
Mark
Uncovering immune cell-associated genes in breast cancer : based on summary data-based Mendelian randomized analysis and colocalization study
(
- Contribution to journal › Article
-
Mark
Low-dose tamoxifen treatment reduces collagen organisation indicative of tissue stiffness in the normal breast : results from the KARISMA randomised controlled trial
(
- Contribution to journal › Article
-
Mark
WHO-recommended levels of physical activity in relation to mammographic breast density, mammographic tumor appearance, and mode of detection of breast cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Impact of breast density on diagnostic accuracy in digital breast tomosynthesis versus digital mammography : results from a European screening trial
(
- Contribution to journal › Article
-
Mark
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2 : the BRCA1 and BRCA2 Cohort Consortium
(
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
(
- Contribution to journal › Article
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
(
- Contribution to journal › Article